TRUSCREEN GROUP LTD

TruScreen Group Ltd. secures a 15% oversubscribed rights issue, raising NZ$4M to fund breakthrough cervical cancer screening tech amid financial challenges.

Truscreen Group Ltd’s non-executive director Juliet Hull has resigned, effective September 11, 2025, while the company also announces a capital change involving the issuance of 1,701,576 ordinary shares.